Carbamazepine-induced AGEP is an uncommon but serious reaction, which, in rare cases, can lead to DKA. The presence of both conditions simultaneously complicates treatment, as interventions for one may worsen the other. Effective management of these overlapping issues, particularly in patients with multiple health concerns, requires a cautious and collaborative approach.
Bastola et al. (Tue,) studied this question.